+关注
摩尔拉雅
暂无个人介绍
IP属地:未知
1
关注
1
粉丝
1
主题
0
勋章
主贴
热门
摩尔拉雅
2021-10-28
$腾盛博药-B(02137)$
30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了
摩尔拉雅
2021-10-04
$腾盛博药-B(02137)$
市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了
摩尔拉雅
2022-01-25
$腾盛博药-B(02137)$
默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物
摩尔拉雅
2022-03-01
$腾盛博药-B(02137)$
等了那么久,终于转灯了,坐等药物上线
摩尔拉雅
2022-03-01
$中国人寿(LFC)$
到底什么情况
摩尔拉雅
2022-01-25
$中国人寿(LFC)$
稳啊
摩尔拉雅
2021-12-22
$中电控股(00002)$
只能看看
摩尔拉雅
2021-12-22
看看
@港股研究社:中电控股Q2收入407.29亿港元,同比增加5.24%
摩尔拉雅
2021-11-23
不是吧
@快手抄底王:
$联想控股(03396)$
柳传志是汉奸
摩尔拉雅
2021-11-23
$联想控股(03396)$
有想法?
摩尔拉雅
2021-11-23
$安山金控(00033)$
没人了?
摩尔拉雅
2021-10-28
这篇文章不错,转发给大家看
@雷递:先通医药完成3.2亿元融资 国寿大健康基金和大钲资本领投
摩尔拉雅
2021-10-28
这篇文章不错,转发给大家看
@紫荆财智:国寿走势转强可续跟进
摩尔拉雅
2021-10-04
这篇文章不错,转发给大家看
外媒头条:拜登称基建法案可以等,刺激法案可以缩
摩尔拉雅
2021-10-04
应该应该吧
抱歉,原内容已删除
摩尔拉雅
2021-10-04
是吗?
默沙东新冠口服药物仍无法替代疫苗作用,抗疫股被错杀?
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4090325469879100,"uuid":"4090325469879100","gmtCreate":1627222405758,"gmtModify":1627227095463,"name":"摩尔拉雅","pinyin":"melymoerlaya","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":1,"tweetSize":16,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":636741362,"gmtCreate":1646118718801,"gmtModify":1646118718801,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","text":"$腾盛博药-B(02137)$等了那么久,终于转灯了,坐等药物上线","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636741362","isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636743761,"gmtCreate":1646118651289,"gmtModify":1646118651289,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","text":"$中国人寿(LFC)$到底什么情况","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636743761","isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062310,"gmtCreate":1643088892676,"gmtModify":1643088892676,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","text":"$腾盛博药-B(02137)$默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062310","isVote":1,"tweetType":1,"viewCount":1091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062993,"gmtCreate":1643088872126,"gmtModify":1643088872126,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","text":"$中国人寿(LFC)$稳啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062993","isVote":1,"tweetType":1,"viewCount":702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183952,"gmtCreate":1640149178699,"gmtModify":1640149178699,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","listText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","text":"$中电控股(00002)$只能看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183952","isVote":1,"tweetType":1,"viewCount":853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183043,"gmtCreate":1640149160999,"gmtModify":1640149160999,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"看看","listText":"看看","text":"看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183043","repostId":"804640704","repostType":1,"repost":{"id":804640704,"gmtCreate":1627955620708,"gmtModify":1627955729447,"author":{"id":"3516422794850265","authorId":"3516422794850265","authorIdStr":"3516422794850265","name":"港股研究社","avatar":"https://static.tigerbbs.com/6f93253ece299c58b5ce6c809885d9ed","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"中电控股Q2收入407.29亿港元,同比增加5.24%","htmlText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","listText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","text":"港股研究社获悉,据智通财经消息,中电控股$中电控股(00002)$ 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","images":[{"img":"https://static.tigerbbs.com/130be0a9ca037f88f69b749a1b3583a0","width":"687","height":"693"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804640704","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692999,"gmtCreate":1637639495676,"gmtModify":1637639495676,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"不是吧","listText":"不是吧","text":"不是吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692999","repostId":"872697344","repostType":1,"repost":{"id":872697344,"gmtCreate":1637498719260,"gmtModify":1637498719260,"author":{"id":"3554843151269467","authorId":"3554843151269467","authorIdStr":"3554843151269467","name":"快手抄底王","avatar":"https://static.tigerbbs.com/9882ecdbb58ceb66dddc323a8ab87a68","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","text":"$联想控股(03396)$柳传志是汉奸","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872697344","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":828,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692092,"gmtCreate":1637639484090,"gmtModify":1637639484090,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","text":"$联想控股(03396)$有想法?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692092","isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875696430,"gmtCreate":1637639459635,"gmtModify":1637639459635,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","listText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","text":"$安山金控(00033)$没人了?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875696430","isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855732132,"gmtCreate":1635399908083,"gmtModify":1635402447041,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","text":"$腾盛博药-B(02137)$30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855732132","isVote":1,"tweetType":1,"viewCount":1759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736172,"gmtCreate":1635399822836,"gmtModify":1635399822836,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736172","repostId":"853292692","repostType":1,"repost":{"id":853292692,"gmtCreate":1634811243715,"gmtModify":1634811243715,"author":{"id":"3520120256277227","authorId":"3520120256277227","authorIdStr":"3520120256277227","name":"雷递","avatar":"https://static.tigerbbs.com/c1d76d196de1b078825d97644631d0f1","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"先通医药完成3.2亿元融资 国寿大健康基金和大钲资本领投","htmlText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","listText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","text":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","images":[{"img":"https://static.tigerbbs.com/1e412d5fe338ad36aa0a8dde63455c4f"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853292692","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736346,"gmtCreate":1635399815870,"gmtModify":1635399815870,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736346","repostId":"851122079","repostType":1,"repost":{"id":851122079,"gmtCreate":1634883866090,"gmtModify":1634884068988,"author":{"id":"3556666140891757","authorId":"3556666140891757","authorIdStr":"3556666140891757","name":"紫荆财智","avatar":"https://static.tigerbbs.com/9be2735744f718237d3b5ef362758bb9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"国寿走势转强可续跟进","htmlText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","listText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","text":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","images":[{"img":"https://static.tigerbbs.com/01b4136dcc2068934838b7c063139597"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851122079","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042872,"gmtCreate":1633331940812,"gmtModify":1633331940812,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","text":"$腾盛博药-B(02137)$市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042872","isVote":1,"tweetType":1,"viewCount":671,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042910,"gmtCreate":1633331871863,"gmtModify":1633331871863,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042910","repostId":"2172396270","repostType":4,"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046762,"gmtCreate":1633331844220,"gmtModify":1633331844220,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"应该应该吧","listText":"应该应该吧","text":"应该应该吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046762","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046522,"gmtCreate":1633331815586,"gmtModify":1633331815586,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"是吗?","listText":"是吗?","text":"是吗?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046522","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":855732132,"gmtCreate":1635399908083,"gmtModify":1635402447041,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","text":"$腾盛博药-B(02137)$30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855732132","isVote":1,"tweetType":1,"viewCount":1759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042872,"gmtCreate":1633331940812,"gmtModify":1633331940812,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","text":"$腾盛博药-B(02137)$市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042872","isVote":1,"tweetType":1,"viewCount":671,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062310,"gmtCreate":1643088892676,"gmtModify":1643088892676,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","text":"$腾盛博药-B(02137)$默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062310","isVote":1,"tweetType":1,"viewCount":1091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636741362,"gmtCreate":1646118718801,"gmtModify":1646118718801,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","text":"$腾盛博药-B(02137)$等了那么久,终于转灯了,坐等药物上线","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636741362","isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636743761,"gmtCreate":1646118651289,"gmtModify":1646118651289,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","text":"$中国人寿(LFC)$到底什么情况","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636743761","isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062993,"gmtCreate":1643088872126,"gmtModify":1643088872126,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","text":"$中国人寿(LFC)$稳啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062993","isVote":1,"tweetType":1,"viewCount":702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183952,"gmtCreate":1640149178699,"gmtModify":1640149178699,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","listText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","text":"$中电控股(00002)$只能看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183952","isVote":1,"tweetType":1,"viewCount":853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183043,"gmtCreate":1640149160999,"gmtModify":1640149160999,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"看看","listText":"看看","text":"看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183043","repostId":"804640704","repostType":1,"repost":{"id":804640704,"gmtCreate":1627955620708,"gmtModify":1627955729447,"author":{"id":"3516422794850265","authorId":"3516422794850265","authorIdStr":"3516422794850265","name":"港股研究社","avatar":"https://static.tigerbbs.com/6f93253ece299c58b5ce6c809885d9ed","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"中电控股Q2收入407.29亿港元,同比增加5.24%","htmlText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","listText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","text":"港股研究社获悉,据智通财经消息,中电控股$中电控股(00002)$ 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","images":[{"img":"https://static.tigerbbs.com/130be0a9ca037f88f69b749a1b3583a0","width":"687","height":"693"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804640704","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692999,"gmtCreate":1637639495676,"gmtModify":1637639495676,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"不是吧","listText":"不是吧","text":"不是吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692999","repostId":"872697344","repostType":1,"repost":{"id":872697344,"gmtCreate":1637498719260,"gmtModify":1637498719260,"author":{"id":"3554843151269467","authorId":"3554843151269467","authorIdStr":"3554843151269467","name":"快手抄底王","avatar":"https://static.tigerbbs.com/9882ecdbb58ceb66dddc323a8ab87a68","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","text":"$联想控股(03396)$柳传志是汉奸","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872697344","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":828,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692092,"gmtCreate":1637639484090,"gmtModify":1637639484090,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","text":"$联想控股(03396)$有想法?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692092","isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875696430,"gmtCreate":1637639459635,"gmtModify":1637639459635,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","listText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","text":"$安山金控(00033)$没人了?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875696430","isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736172,"gmtCreate":1635399822836,"gmtModify":1635399822836,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736172","repostId":"853292692","repostType":1,"repost":{"id":853292692,"gmtCreate":1634811243715,"gmtModify":1634811243715,"author":{"id":"3520120256277227","authorId":"3520120256277227","authorIdStr":"3520120256277227","name":"雷递","avatar":"https://static.tigerbbs.com/c1d76d196de1b078825d97644631d0f1","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"先通医药完成3.2亿元融资 国寿大健康基金和大钲资本领投","htmlText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","listText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","text":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","images":[{"img":"https://static.tigerbbs.com/1e412d5fe338ad36aa0a8dde63455c4f"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853292692","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736346,"gmtCreate":1635399815870,"gmtModify":1635399815870,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736346","repostId":"851122079","repostType":1,"repost":{"id":851122079,"gmtCreate":1634883866090,"gmtModify":1634884068988,"author":{"id":"3556666140891757","authorId":"3556666140891757","authorIdStr":"3556666140891757","name":"紫荆财智","avatar":"https://static.tigerbbs.com/9be2735744f718237d3b5ef362758bb9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"国寿走势转强可续跟进","htmlText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","listText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","text":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","images":[{"img":"https://static.tigerbbs.com/01b4136dcc2068934838b7c063139597"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851122079","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042910,"gmtCreate":1633331871863,"gmtModify":1633331871863,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042910","repostId":"2172396270","repostType":4,"repost":{"id":"2172396270","pubTimestamp":1633296246,"share":"https://www.laohu8.com/m/news/2172396270?lang=&edition=full","pubTime":"2021-10-04 05:24","market":"hk","language":"zh","title":"外媒头条:拜登称基建法案可以等,刺激法案可以缩","url":"https://stock-news.laohu8.com/highlight/detail?id=2172396270","media":"新浪美股","summary":" 美国总统乔·拜登周五调整了民主党对其经济法案的预期,其告诉议员们税收和一揽子支出计划的规模会更小,排除了两党基础设施法案很快获得通过的可能性。 在与众议院民主党人举行的闭门会议上,拜登表示,参议院通过的5500亿美元新基础设施法案可能还需等待。此外,拜登对温和派也表示了支持,同意将一揽子计划的规模从3.5万亿美元下调。","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有:</b></p>\n<blockquote>\n <b>1、拜登:基建法案可以再等等 支出法案的规模可能下调</b>\n</blockquote>\n<blockquote>\n <b>2、</b> \n <b>美国众议长佩洛西将10月31日定为通过基建法案的最新目标期限</b>\n</blockquote>\n<blockquote>\n <b>3、<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>第三季度汽车交付量超24万 创历史新高</b>\n</blockquote>\n<blockquote>\n <b>4、</b> \n <b><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>抗争欧盟50亿美元反垄断罚单:网友用我们是因为体验最好</b>\n</blockquote>\n<blockquote>\n <b>5、经济阴霾令加息前景存疑 BlueBay转为看跌英镑</b>\n</blockquote>\n<blockquote>\n <b>6、</b> \n <b>全球最大石油公司表示 欧佩克+将在未来几个月推动油价上涨</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/699c7a5b8fa2ea5079181d2e3050dc13\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"><b>拜登:基建法案可以再等等 支出法案的规模可能下调</b></p>\n<p>美国总统乔·拜登周五调整了民主党对其经济法案的预期,其告诉议员们税收和一揽子支出计划的规模会更小,排除了两党基础设施法案很快获得通过的可能性。</p>\n<p>在与众议院民主党人举行的闭门会议上,拜登表示,参议院通过的5500亿美元新基础设施法案可能还需等待。</p>\n<p>拜登同意将基础设施法案与全面扩大社会项目和气候变化联系起来,这对于党内进步派是一个胜利。此外,拜登对温和派也表示了支持,同意将一揽子计划的规模从3.5万亿美元下调。</p>\n<p>民主党人对如何推进拜登的经济议程陷入僵局,温和派坚持认为,应该现在就批准已经在参议院通过的基建法案,而进步派威胁称,如果不同时推出更大规模的一揽子方案,那么就不能批准基建法案。<img src=\"https://static.tigerbbs.com/6f100ea84bd63ce04e21774b52478d2e\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"><b>美国众议长佩洛西将10月31日定为通过基建法案的最新目标期限</b></p>\n<p>美国众议院议长南希·佩洛西将10月31日定为众议院民主党通过两党基建方案的目标日期。佩洛西称,之所以发放弃本周表决的计划是因为无法获得足够票数。</p>\n<p>对于规模5500亿美元的基建支出法案,佩洛西周六在给党团干部的信件中表示,“我们必须尽早通过基建法案,越快越好,把这个事情抓紧完成”。</p>\n<p>为其30天的联邦高速公路项目资金展期方案将在10月底到期。在佩洛西没有将一揽子基建法案付诸表决后,该临时措施在周五获得通过。<img src=\"https://static.tigerbbs.com/5c99d4e798efa018d6eefd07fdebc686\" tg-width=\"512\" tg-height=\"342\" referrerpolicy=\"no-referrer\"><b><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>第三季度汽车交付量超24万 创历史新高</b></p>\n<p>特斯拉第三季度全球汽车交付量达到创纪录的241,300辆,好于预期水平。</p>\n<p>季度交付量是特斯拉最受关注的指标之一。它们也被广泛视为消费者对电动汽车需求的晴雨表。</p>\n<p>特斯拉周六在声明中表示,“我们要感谢客户在我们应对全球供应链和物流挑战时给予的耐心”。</p>\n<p>特斯拉在报告中称,截至2021年9月30日期间,该公司生产了237,823辆汽车。其中,228,882辆是其Model 3和Y型汽车,它们是更实惠的中档产品。其余生产量达8,941辆Model S和X。上个季度,特斯拉交付了201,250辆汽车,生产了206,421辆汽车,即使其Model S和X汽车的产量低于2,500辆。<img src=\"https://static.tigerbbs.com/52252c4277c33e9c45e6d096267405da\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"><b><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>抗争欧盟50亿美元反垄断罚单:网友用我们是因为体验最好</b></p>\n<p><a href=\"https://laohu8.com/S/SINA\">新浪</a>科技讯 北京时间10月3日早间消息,据报道,之前,欧盟委员会以“安卓操作系统存在垄断行为”为由,对美国谷歌公司开出创纪录的50亿美元罚款单。谷歌不服裁决提出上诉,而在近日的法庭听证会上,谷歌律师表示,全世界几十亿的网友使用谷歌的互联网服务,是因为服务体验最佳,而不是谷歌为保持市场竞争优势进行的一些合作交易。</p>\n<p>2018年,欧盟委员会对谷歌开出了43.4亿欧元(相当于50亿美元)的罚单。该机构指出,谷歌滥用安卓操作系统的竞争优势,打击对手,并且进一步巩固在通用网页搜索领域的领先地位。</p>\n<p>欧盟委员会指控谷歌进行了一系列不公平交易,其中包括要求第三方智能手机制造商预装谷歌搜索、谷歌Play软件商店,Chrome浏览器等软件,谷歌还达成协议,要求手机厂商停用安卓系统的(非谷歌官方)定制版本。</p>\n<p>谷歌对于欧盟委员会的裁决提出了司法上诉。日前在欧洲普通法院(欧盟内部第二大高等法院),谷歌律师梅利德斯·皮克福德(Meredith Pickford)对法官表示,每天,全世界几十亿互联网用户使用谷歌作为他们的主要搜索工具,这并不是谷歌滥用了主导地位,而是因为谷歌搜索是行业内最好的。<img src=\"https://static.tigerbbs.com/72a4340be35f736767dc6b2a7236b70e\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"><b>经济阴霾令加息前景存疑 BlueBay转为看跌英镑</b></p>\n<p>英镑正在失宠,因为对英国经济的悲观情绪导致市场怀疑英国央行能否实现交易员所预期的加息。</p>\n<p>对明年收紧政策的预期升温,两年期英国国债收益率升至新冠疫情开始以来最高水平。尽管如此,BlueBay Asset Management LLP和野村国际本周转为对英镑看跌,<a href=\"https://laohu8.com/S/DB\">德意志银行</a>下调了年底预测。</p>\n<p>能源价格飞涨、通胀担忧以及休假计划的结束,都让央行的鹰派前景黯然失色。这足以促使BlueBay对英镑的立场从中性转为看空,Mark Dowding称。他在该公司管理着700亿美元的资产。</p>\n<p>“在公共事业费用和其他成本飙升的背景下,英国通胀率可能在新年升至6%,”Dowding说。他预计,如果高通胀和缓慢增长的现象根深蒂固,那么未来六个月英镑将下跌10%。“因此,英国央行可能手足无措。英国央行听起来鹰派,但如果增长令人失望,则可能需要改变立场。”<img src=\"https://static.tigerbbs.com/c71529e2a652060f1efe9e18078c0026\" tg-width=\"550\" tg-height=\"275\" referrerpolicy=\"no-referrer\"><b>全球最大石油公司表示 欧佩克+将在未来几个月推动油价上涨</b></p>\n<p>据维多集团称,欧佩克+的生产政策将是未来几个月影响油价的主要因素。</p>\n<p>这家全球最大的独立石油交易商表示,今年伊朗石油重返全球市场的可能性很小,而且美国页岩油生产商的投资不足以迅速提高产量。</p>\n<p>“定价控制权在很大程度上掌握在OPEC+手中,”维多集团亚洲区负责人迈克穆勒在周日的网络研讨会上表示。在美国,“如果你需要额外的石油,钻井数量根本无法充分供应。”</p>\n<p>随着布伦特原油上周自2018年以来首次攀升至每桶80美元以上,一些交易员呼吁欧佩克+宣布更快的产量增长计划。</p>\n<p>欧佩克+正在逐步放松自去年新冠疫情席卷能源市场以来开始的减产。他们此前曾表示,将在2022年中期之前每月将日产量提高40万桶。</p>\n<p>欧洲天然气短缺加剧了石油市场的紧张局面,企业被迫改用原油生产电力。</p>\n<p>迈克穆勒说,一些欧佩克+成员国给人的印象是,他们并不担心油价超过80美元可能会抑制需求。</p>","source":"sina_us","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条:拜登称基建法案可以等,刺激法案可以缩</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条:拜登称基建法案可以等,刺激法案可以缩\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 05:24 北京时间 <a href=https://finance.sina.com.cn/stock/usstock/c/2021-10-04/doc-iktzqtyt9570075.shtml><strong>新浪美股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有:\n\n1、拜登:基建法案可以再等等 支出法案的规模可能下调\n\n\n2、\n美国众议长佩洛西将10月31日定为通过基建法案的最新目标期限\n\n\n3、特斯拉第三季度汽车交付量超24万 创历史新高\n\n\n4、\n谷歌抗争欧盟50亿美元反垄断罚单:网友用我们是因为体验最好\n\n\n5、经济阴霾令加息前景存疑 BlueBay转为看跌英镑\n\n\n6、\n全球最大石油公司表示 欧佩克+...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-10-04/doc-iktzqtyt9570075.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/699c7a5b8fa2ea5079181d2e3050dc13","relate_stocks":{"GOOGL":"谷歌A",".SPX":"S&P 500 Index","FXB":"英镑ETF-CurrencyShares","TSLA":"特斯拉","UCO":"二倍做多彭博原油ETF","SCO":"二倍做空彭博原油指数ETF","GOOG":"谷歌",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-10-04/doc-iktzqtyt9570075.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172396270","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有:\n\n1、拜登:基建法案可以再等等 支出法案的规模可能下调\n\n\n2、\n美国众议长佩洛西将10月31日定为通过基建法案的最新目标期限\n\n\n3、特斯拉第三季度汽车交付量超24万 创历史新高\n\n\n4、\n谷歌抗争欧盟50亿美元反垄断罚单:网友用我们是因为体验最好\n\n\n5、经济阴霾令加息前景存疑 BlueBay转为看跌英镑\n\n\n6、\n全球最大石油公司表示 欧佩克+将在未来几个月推动油价上涨\n\n拜登:基建法案可以再等等 支出法案的规模可能下调\n美国总统乔·拜登周五调整了民主党对其经济法案的预期,其告诉议员们税收和一揽子支出计划的规模会更小,排除了两党基础设施法案很快获得通过的可能性。\n在与众议院民主党人举行的闭门会议上,拜登表示,参议院通过的5500亿美元新基础设施法案可能还需等待。\n拜登同意将基础设施法案与全面扩大社会项目和气候变化联系起来,这对于党内进步派是一个胜利。此外,拜登对温和派也表示了支持,同意将一揽子计划的规模从3.5万亿美元下调。\n民主党人对如何推进拜登的经济议程陷入僵局,温和派坚持认为,应该现在就批准已经在参议院通过的基建法案,而进步派威胁称,如果不同时推出更大规模的一揽子方案,那么就不能批准基建法案。美国众议长佩洛西将10月31日定为通过基建法案的最新目标期限\n美国众议院议长南希·佩洛西将10月31日定为众议院民主党通过两党基建方案的目标日期。佩洛西称,之所以发放弃本周表决的计划是因为无法获得足够票数。\n对于规模5500亿美元的基建支出法案,佩洛西周六在给党团干部的信件中表示,“我们必须尽早通过基建法案,越快越好,把这个事情抓紧完成”。\n为其30天的联邦高速公路项目资金展期方案将在10月底到期。在佩洛西没有将一揽子基建法案付诸表决后,该临时措施在周五获得通过。特斯拉第三季度汽车交付量超24万 创历史新高\n特斯拉第三季度全球汽车交付量达到创纪录的241,300辆,好于预期水平。\n季度交付量是特斯拉最受关注的指标之一。它们也被广泛视为消费者对电动汽车需求的晴雨表。\n特斯拉周六在声明中表示,“我们要感谢客户在我们应对全球供应链和物流挑战时给予的耐心”。\n特斯拉在报告中称,截至2021年9月30日期间,该公司生产了237,823辆汽车。其中,228,882辆是其Model 3和Y型汽车,它们是更实惠的中档产品。其余生产量达8,941辆Model S和X。上个季度,特斯拉交付了201,250辆汽车,生产了206,421辆汽车,即使其Model S和X汽车的产量低于2,500辆。谷歌抗争欧盟50亿美元反垄断罚单:网友用我们是因为体验最好\n新浪科技讯 北京时间10月3日早间消息,据报道,之前,欧盟委员会以“安卓操作系统存在垄断行为”为由,对美国谷歌公司开出创纪录的50亿美元罚款单。谷歌不服裁决提出上诉,而在近日的法庭听证会上,谷歌律师表示,全世界几十亿的网友使用谷歌的互联网服务,是因为服务体验最佳,而不是谷歌为保持市场竞争优势进行的一些合作交易。\n2018年,欧盟委员会对谷歌开出了43.4亿欧元(相当于50亿美元)的罚单。该机构指出,谷歌滥用安卓操作系统的竞争优势,打击对手,并且进一步巩固在通用网页搜索领域的领先地位。\n欧盟委员会指控谷歌进行了一系列不公平交易,其中包括要求第三方智能手机制造商预装谷歌搜索、谷歌Play软件商店,Chrome浏览器等软件,谷歌还达成协议,要求手机厂商停用安卓系统的(非谷歌官方)定制版本。\n谷歌对于欧盟委员会的裁决提出了司法上诉。日前在欧洲普通法院(欧盟内部第二大高等法院),谷歌律师梅利德斯·皮克福德(Meredith Pickford)对法官表示,每天,全世界几十亿互联网用户使用谷歌作为他们的主要搜索工具,这并不是谷歌滥用了主导地位,而是因为谷歌搜索是行业内最好的。经济阴霾令加息前景存疑 BlueBay转为看跌英镑\n英镑正在失宠,因为对英国经济的悲观情绪导致市场怀疑英国央行能否实现交易员所预期的加息。\n对明年收紧政策的预期升温,两年期英国国债收益率升至新冠疫情开始以来最高水平。尽管如此,BlueBay Asset Management LLP和野村国际本周转为对英镑看跌,德意志银行下调了年底预测。\n能源价格飞涨、通胀担忧以及休假计划的结束,都让央行的鹰派前景黯然失色。这足以促使BlueBay对英镑的立场从中性转为看空,Mark Dowding称。他在该公司管理着700亿美元的资产。\n“在公共事业费用和其他成本飙升的背景下,英国通胀率可能在新年升至6%,”Dowding说。他预计,如果高通胀和缓慢增长的现象根深蒂固,那么未来六个月英镑将下跌10%。“因此,英国央行可能手足无措。英国央行听起来鹰派,但如果增长令人失望,则可能需要改变立场。”全球最大石油公司表示 欧佩克+将在未来几个月推动油价上涨\n据维多集团称,欧佩克+的生产政策将是未来几个月影响油价的主要因素。\n这家全球最大的独立石油交易商表示,今年伊朗石油重返全球市场的可能性很小,而且美国页岩油生产商的投资不足以迅速提高产量。\n“定价控制权在很大程度上掌握在OPEC+手中,”维多集团亚洲区负责人迈克穆勒在周日的网络研讨会上表示。在美国,“如果你需要额外的石油,钻井数量根本无法充分供应。”\n随着布伦特原油上周自2018年以来首次攀升至每桶80美元以上,一些交易员呼吁欧佩克+宣布更快的产量增长计划。\n欧佩克+正在逐步放松自去年新冠疫情席卷能源市场以来开始的减产。他们此前曾表示,将在2022年中期之前每月将日产量提高40万桶。\n欧洲天然气短缺加剧了石油市场的紧张局面,企业被迫改用原油生产电力。\n迈克穆勒说,一些欧佩克+成员国给人的印象是,他们并不担心油价超过80美元可能会抑制需求。","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046762,"gmtCreate":1633331844220,"gmtModify":1633331844220,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"应该应该吧","listText":"应该应该吧","text":"应该应该吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046762","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046522,"gmtCreate":1633331815586,"gmtModify":1633331815586,"author":{"id":"4090325469879100","authorId":"4090325469879100","authorIdStr":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"是吗?","listText":"是吗?","text":"是吗?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046522","repostId":"2172998592","repostType":4,"repost":{"id":"2172998592","pubTimestamp":1633327800,"share":"https://www.laohu8.com/m/news/2172998592?lang=&edition=full","pubTime":"2021-10-04 14:10","market":"hk","language":"zh","title":"默沙东新冠口服药物仍无法替代疫苗作用,抗疫股被错杀?","url":"https://stock-news.laohu8.com/highlight/detail?id=2172998592","media":"第一财经","summary":"Molnupiravir如果获得授权使用,会对重构现有相关新冠药物市场格局。","content":"<div>\n<p>10月4日,港股市场开盘后,抗疫股几乎全线重挫。这些股票暴跌的背后,导火线跟默沙东与Ridgeback合作开发的在研抗病毒口服药物Molnupiravir临床研究有新进展有关。\n默沙东近期对外公布称,Molnupiravir在对轻度或中度新冠肺炎患者开展的3期研究中,获得积极的期中分析结果。与安慰剂相比,Molnupiravir降低了患者住院或死亡的风险约50%。在期中分析中,截至第29天,接受...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202110042129029063_0.html\">Web Link</a>\n\n</div>\n","source":"eastmoney_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>默沙东新冠口服药物仍无法替代疫苗作用,抗疫股被错杀?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n默沙东新冠口服药物仍无法替代疫苗作用,抗疫股被错杀?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 14:10 北京时间 <a href=http://finance.eastmoney.com/a/202110042129029063_0.html><strong>第一财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>10月4日,港股市场开盘后,抗疫股几乎全线重挫。这些股票暴跌的背后,导火线跟默沙东与Ridgeback合作开发的在研抗病毒口服药物Molnupiravir临床研究有新进展有关。\n默沙东近期对外公布称,Molnupiravir在对轻度或中度新冠肺炎患者开展的3期研究中,获得积极的期中分析结果。与安慰剂相比,Molnupiravir降低了患者住院或死亡的风险约50%。在期中分析中,截至第29天,接受...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202110042129029063_0.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3","relate_stocks":{"MRK":"默沙东"},"source_url":"http://finance.eastmoney.com/a/202110042129029063_0.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172998592","content_text":"10月4日,港股市场开盘后,抗疫股几乎全线重挫。这些股票暴跌的背后,导火线跟默沙东与Ridgeback合作开发的在研抗病毒口服药物Molnupiravir临床研究有新进展有关。\n默沙东近期对外公布称,Molnupiravir在对轻度或中度新冠肺炎患者开展的3期研究中,获得积极的期中分析结果。与安慰剂相比,Molnupiravir降低了患者住院或死亡的风险约50%。在期中分析中,截至第29天,接受Molnupiravir治疗的患者中有7.3%患者住院,而接受安慰剂的患者中有14.1%的患者住院或死亡。\n默沙东表示,在独立数据监查委员会的建议下,经与美国食品药品监督管理局(FDA)磋商,由于上述积极的结果,这项研究的招募工作提前终止。基于上述研究结果,公司计划尽快向美国食品药品监督管理局(FDA)提交紧急使用授权(EUA)申请,并计划向全球多家监管机构提交上市申请。如果获得授权,Molnupiravir有望成为首款治疗新冠肺炎的抗病毒口服药物。\nMolnupiravir(EIDD-2801/MK-4482)是一种在研的、生物可利用形式为口服的核糖核苷类似物,可抑制包括SARS-CoV-2(新冠病毒的致病因子)在内的多种RNA病毒的复制。\nRidgeback总裁Wendy Holman表示:“随着病毒持续广泛传播,由于目前可用的治疗方案是输液或需要进入医疗机构,我们迫切需要可以在家里服用的抗病毒治疗方案,让新冠肺炎患者不用去医院。我们对期中分析的结果感到非常鼓舞,并希望Molnupiravir在获得授权使用后,能够对控制这场大流行产生意义深远的影响。”\n有市场猜测称,Molnupiravir如果获得授权使用,会对重构现有相关新冠药物市场格局。\nMolnupiravir属于小分子口服药物,相比目前已获批紧急使用授权的新冠中和抗体,给药便利是一大优势。“从目前数据看,Molnupiravir治疗效果不错,或有望成为‘达菲’对流感一样的特效药。同时,Molnupiravir的生产成本也比较低。不过,早些时候有研究表明,该药在哺乳细胞身上有一定的机率导致突变,届时能否获批使用,还要看届时FDA如何评测了。”有投资人对第一财经记者表示。\n该投资人对第一财经记者表示,目前资本市场的反应有些过度,这次股价出现调整,不排除跟前期涨幅过快、估值泡沫过大有关,市场也在借机调整。\n“Molnupiravir对其他新冠药物的影响,要分开来看,对于治疗性药物,比如中和抗体,可能会构成重大利空,从治疗数据看,Molnupiravir具有一定的优势,获批的可能性比较大。而一旦获批的话,不排除会被政府大规模采购,这样一来的话,其他治疗性药物的市场会被抢占。但对于疫苗来说,影响不大,预防性的疫苗与治疗性药物,属于完全不同的两个概念。疫苗仍是预防新冠肺炎最经济、最有效的措施。疫苗股大跌,是前期涨幅过大后的一次回调。”另有其他投资人对第一财经记者表示。","news_type":1},"isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}